XML 36 R27.htm IDEA: XBRL DOCUMENT v3.23.2
STOCKHOLDERS EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
May 31, 2023
Apr. 30, 2023
Oct. 28, 2022
Feb. 28, 2022
Dec. 31, 2021
Nov. 30, 2021
Nov. 18, 2021
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Sep. 30, 2022
Incremental cost                 $ 294,000   $ 294,000  
Common stock shares issued   794,117           44,748,437   44,748,437   43,448,317
Public offering price   $ 1.70                    
Proceeds from the Sale of Common Stock   $ 1,200,000               $ 1,391,897 0  
Additional common stock shares issued to underwriters 119,117                      
Proceeds from additional shares of common stock $ 190,000                      
Consulting Agreements [Member]                        
Total expense               $ 188,000 $ 201,000 474,000 $ 603,000  
Consulting fees inclued prepaid expenses               $ 204,000   $ 204,000   $ 295,000
Consultants [Member]                        
Exercise price                   $ 11.61    
Options issued                   5,000    
Restricted Stock [Member] | Consultants [Member]                        
Weighted average grant date fair value               $ 2.41 $ 3.52 $ 2.45 $ 5.40  
Common stock issued for service, shares               36,523 38,287 115,321 81,782  
Series AA [Member]                        
Warrants exercised       100,000                
Exercise price per share       $ 13.75                
Series NN [Member]                        
Warrants exercised                     10,000  
Proceeds from warrants exercised                     $ 25,200  
Exercise Price                     $ 2.52  
Interest expense                 $ 635,000   $ 635,000  
Series RR [Member]                        
Incremental cost     $ 172,000                  
Warrants exercised                   17,752    
Exercise Price                   $ 1.65    
Series TT [Member]                        
Warrants exercised                   600    
Exercise Price                   $ 2.24    
Series CC [Member]                        
Warrants exercised         640           15,205  
Proceeds from warrants exercised                     $ 76,025  
Exercise price per share         $ 5.00           $ 5.00  
Series HH [Member]                        
Warrants exercised       200                
Exercise price per share       $ 3.13                
Series Z [Member]                        
Warrants exercised           184,800            
Exercise Price           $ 13.75            
Series SS [Member]                        
Warrants exercised                   200,000    
Proceeds from warrants exercised                   $ 447,291    
Exercise Price                   $ 2.09    
Non-Qualified Stock Option Plans [Member]                        
Grant performance-based stock options             250,000          
Common stock price             $ 10.48          
Percentage of vested Stock options             100.00%          
Options vested               10,000   10,000    
Options issued to consultants               10,000   10,000